(Q36047567)

11 August 2017

Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo (English)

1 reference

Mycobacterium tuberculosis

11 August 2017

0 references

1

Nicolas Veziris

1 reference

11 August 2017

Chantal Truffot-Pernot

2

1 reference

11 August 2017

Alexandra Aubry

3

1 reference

11 August 2017

Vincent Jarlier

4

1 reference

11 August 2017

Nacer Lounis

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

1 reference

11 August 2017

47

1 reference

11 August 2017

10

1 reference

11 August 2017

3117-3122

1 reference

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Role of individual drugs in the chemotherapy of tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201131

[The adverse reactions of anti-tuberculosis drugs and its management]

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14506018

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14506018

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.47.10.3117-3122.2003

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

14506018

1 reference